Skadden is advising Paratek Pharmaceuticals in the transaction, Hogan Lovells is advising Optinose.Paratek Pharmaceuticals and Optinose, Inc. (NASDAQ:OPTN) have entered into a definitive merger agreement under…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
